Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.

NCT07443774 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

81

Enrollment

OTHER

Sponsor class

Conditions

ER+ Breast Cancer
Breast Cancer
Early Breast Cancer
Endocrine Therapy
Abemaciclib
Ribociclib

Sponsor

University Hospital, Grenoble